TEMPE, Ariz. — Aptyx, a global designer, developer, and manufacturer of complex life science devices and components, announced the acquisition of Argos Corporation, a Massachusetts-based precision extrusion company known for its materials expertise and advanced manufacturing technologies. The acquisition will allow Aptyx to expand its precision extrusion portfolio and establish a new Precision Extrusion Center of Excellence in the Boston medtech corridor, adding immediate capacity, enhanced technical capabilities, and in-house engineering support for interventional-device innovation.
Gregg Tobin, President and CEO of Aptyx, said the expansion strengthens the company’s long-term growth strategy. “This marks another milestone in our growth strategy, further enhancing our ability to provide integrated expertise and innovation for our OEM Life Science customers,” he said. “This new center perfectly complements our Interventional Center of Excellence in Charlotte, where we have a long history of supporting complex transcatheter implants and delivery systems from early design to finished device manufacturing.”
Aptyx has built a strong presence in extrusion technologies, supplying core mandrels and specialty tubing for sleep, respiratory, and anesthesia applications. The new center builds on this foundation by adding catheter-grade precision, expanded scale, and advanced extrusion capabilities aimed at supporting next-generation interventional systems.
The Boston-area Precision Extrusion Center of Excellence will offer a broad range of capabilities, including high-precision tubing with wall thicknesses as thin as .001 inches and ID/OD tolerances down to .0005 inches. The facility will provide quick-turn development and controlled-environment manufacturing, in-house tooling design, and support for a wide range of materials and complex extrusion formats such as multi-lumen, tapered, co-extrusion, multi-layer, balloon tubing, micro extrusions, and more. Customers will also receive high-touch collaboration and comprehensive quality assurance.
With this expansion, Aptyx increases its capacity to serve interventional and catheter-based device markets with greater speed, scalability, and technical depth. The new center strengthens the company’s fully integrated design and manufacturing platform, which includes molding, extrusion, coating technologies, and finished-device assembly—supporting customers from concept through commercialization.
Patrick Daly, Director of Global Extrusion at Aptyx, said the investment positions the company to push innovation further. “We’re committed to conquering technical challenges and advancing what’s possible in medical tubing,” he said. “This expansion deepens our extrusion expertise and enhances how we bring specialized strengths together across Aptyx to drive Medtech advancement.”
